ATAI
ATAI
NASDAQ · Pharmaceuticals

Ataibeckley Inc

$7.35
+0.06 (+0.82%)
Analyst Consensus
Hold
21
Analysts
High
Coverage
Buy 7 33%
Hold 14 67%
Sell 0 0%
Price Target
Analyst Price Target +450.2% upside
Low Target $27.58
Average Target $40.44
High Target $50.46
Current Price $7.35
Current
$7.35
Target
$40.44
$27.58 $40.44 avg $50.46
Scenario Analysis
Bear Case
$27.58
275.2%
Low target
Base Case
$40.44
+450.2%
Avg target
Bull Case
$50.46
+586.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.45
-1.3% from high
52-Week Low
$3.27
+125.1% from low
Target vs 52W High
$40.44
+442.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%